Sponsor Pipeline

CellSight Technologies, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03684655 Imaging Immune Activation in HIV by PET-MR HIV Infections Recruiting
NCT06084806 Test-retest Evaluation of [18F]F-AraG PET Non-small Cell Lung Cancer Recruiting
NCT06107374 Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG Advanced Non Small Cell Lung Cancer Recruiting
NCT04815096 Imaging Immune Activation in COVID-19 Covid19 Recruiting
NCT07611357 [18F]F-AraG PET Imaging in Alzheimer's Disease Alzheimer Disease (AD) Not Yet Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Alzheimer's Disease (1)
Get alerts when CellSight Technologies, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free